OAT PINs and DINs
The table below provides appropriate PINs and DINs for PharmaCare claims for opiate agonist therapy (OAT) treatments for opioid use disorder. PINs listed are for OAT claims only.
For more information on OAT and current methadone formulations, please see the BC Centre on Substance Use bulletin (PDF, 480 KB).
Interaction Fees
For all eligible direct interaction OAT claims, PharmaCare pays an interaction fee to pharmacies that are:
- enrolled in the Methadone Maintenance Sub-Class; and
- dispensing methadone with direct interaction
Plan B claims are excluded from interaction fees. Eligible claims include those for Fair PharmaCare beneficiaries who have not met their deductible.
Pain Indications
Many of the drugs listed below may be prescribed for pain. If a prescription is for pain, enter the transaction in PharmaNet with the correct DIN.
Do not use OAT PINs for pain indications.
| Drug | DIN/PIN for OAT Claims | Plan Coverage | Claim Submission Requirements |
|---|---|---|---|
| Methadose™ 10mg/mL (cherry) | 66999997 (PIN) |
Covered under plans: Maximum one dispensing fee and one interaction fee per patient per day. |
Claim quantity must be submitted as total mLs. SIG must include dose in mg & mL (e.g. Take 5mLs (50mg) once daily.) SIG must include the start and end dates of the prescription. Carries must be claimed as single multiple-day supply for drug cost, plus a single dispensing fee. A single interaction fee will be paid for the first witnessed dose. Split doses must be claimed as a single multiple-dose claim for drug cost, plus a single dispensing fee. A single interaction fee will be paid for the first witnessed dose. |
| Metadol-D® 10mg/mL (unflavoured) | 67000005 (PIN) | ||
|
Methadone (Sterinova®) 10mg/mL |
67000017 (PIN) |
| Drug | DIN/PIN for OAT Claims | Plan Coverage | Claim Submission Requirements |
|---|---|---|---|
| Methadose™ 10mg/mL (cherry) | 66999999 (PIN) |
Covered under plans: Maximum one dispensing fee and one interaction fee per patient per day. |
Claim quantity must be submitted as total mLs. SIG must include dose in mg & mL (e.g. Take 5mLs (50mg) once daily.) SIG must include the start and end dates of the prescription. Carries must be claimed as single multiple-day supply for drug cost, plus a single dispensing fee. A single interaction fee will be paid for the first witnessed dose. Split doses must be claimed as a single multiple-dose claim for drug cost, plus a single dispensing fee. A single interaction fee will be paid for the first witnessed dose. |
|
Metadol-D® 10mg/mL (unflavoured) |
67000007 (PIN) | ||
|
Methadone (Sterinova®) 10mg/mL |
67000018 (PIN) |
| Drug | DIN/PIN for OAT Claims | Plan Coverage | Claim Submission Requirements |
|---|---|---|---|
|
Methadose™ 10mg/mL (cherry) |
66999998 (PIN) |
Covered under plans: |
Claim quantity must be submitted as total mLs. SIG must include dose in mg & mL (e.g. Take 5mLs (50mg) once daily.) SIG must include the start and end dates of the prescription. Carries must be claimed as single multiple-day supply for drug cost, plus a single dispensing fee. A single interaction fee will be paid for the first witnessed dose. Split doses must be claimed as a single multiple-dose claim for drug cost, plus a single dispensing fee. |
|
Metadol-D® 10mg/mL (unflavoured) |
67000006 (PIN) | ||
|
Methadone (Sterinova®) 10mg/mL |
67000020 (PIN) |
| Drug | DIN/PIN for OAT Claims | Plan Coverage | Claim Submission Requirements |
|---|---|---|---|
|
Methadose™ 10mg/mL (cherry) |
67000000 (PIN) |
Covered under plans: |
Claim quantity must be submitted as total mLs. SIG must include dose in mg & mL (e.g. Take 5mLs (50mg) once daily.) SIG must include the start and end dates of the prescription. Carries must be claimed as single multiple-day supply for drug cost, plus a single dispensing fee. A single interaction fee will be paid for the first witnessed dose. Split doses must be claimed as a single multiple-dose claim for drug cost, plus a single dispensing fee. |
|
Metadol-D® 10mg/mL (unflavoured) |
67000008 (PIN) | ||
|
Methadone (Sterinova®) 10mg/mL |
67000019 (PIN) |
| Drug | DIN/PIN for OAT Claims | Plan Coverage | Claim Submission Requirements |
|---|---|---|---|
| Methadose™ 10mg/mL sugar-free
with direct interaction |
67000001 (PIN) | Non-benefit. Special Authority coverage required under plans B, C, G, P, W and Fair PharmaCare. |
See relevant dispense type above for submission requirements. |
| Methadose™ 10mg/mL sugar-free
delivery with direct interaction |
67000003 (PIN) | ||
| Methadose™ 10mg/mL sugar-free
without direct interaction |
67000002 (PIN) | ||
| Methadose™ 10mg/mL sugar-free
delivery without direct interaction |
67000004 (PIN) | ||
| Compounded methadone 10mg/mL
with direct interaction |
67000013 (PIN) |
Non-benefit. Last-resort, exceptional coverage only. Special Authority required. Dispensing pharmacies must order compounded methadone from the central compounding pharmacy. Please contact the BCCSU or the BCPhA for details. |
See relevant dispense type above for submission requirements. |
| Compounded methadone 10mg/mL
delivery with direct interaction |
67000014 (PIN) | ||
| Compounded methadone 10mg/mL
without direct interaction |
67000016 (PIN) | ||
| Compounded methadone 10mg/mL
delivery without direct interaction |
67000015 (PIN) |
| Drug | DIN/PIN for OAT Claims | Plan Coverage | Claim Submission Requirements |
|---|---|---|---|
| Buprenorphine/Naloxone SL 2mg/0.5mg generics | ACT 02453908 |
Covered under plans B, C, G, P, W, and Fair PharmaCare. No interaction fee paid for witnessed ingestion. |
Claim quantity must be submitted as the number of tablets. SIG should include start and end dates as best practice (not mandatory.) |
| PMS 02424851 | |||
| Buprenorphine/Naloxone SL 8mg/2mg generics | ACT 02453916 | ||
| PMS 02424878 | |||
| Suboxone®
Buprenorphine/Naloxone 2mg/0.5mg SL |
02295695 |
Suboxone® is a partial benefit under plans B, C, G, P, W, and Fair PharmaCare. No interaction fee paid for witnessed ingestion. |
Claim quantity must be submitted as the number of tablets. SIG should include start and end dates as best practice (not mandatory.) |
| Suboxone®
Buprenorphine/Naloxone 8mg/2mg SL |
02295709 | ||
| Suboxone®
Buprenorphine/Naloxone 12mg/3mg SL |
02468085 |
Exceptional Special Authority coverage required under plans B, C, G, P, W and Fair PharmaCare. No interaction fee paid for witnessed ingestion. |
|
| Suboxone®
Buprenorphine/Naloxone 16mg/4mg SL |
02468093 | ||
| Kadian® slow-release oral morphine 10mg capsule | 22123349 (PIN) |
Covered for OAT under plans B, C, G, P, W and Fair PharmaCare. No interaction fee paid for witnessed ingestion. |
Submit using PharmaCare PINs if for OAT. Claim quantity must be submitted as the number of capsules. SIG should include start and end dates as best practice (not mandatory.) |
| Kadian® slow-release oral morphine 20mg capsule | 22123346 (PIN) | ||
| Kadian® slow-release oral morphine 50mg capsule | 22123347 (PIN) | ||
| Kadian® slow-release oral morphine 100mg capsule | 22123348 (PIN) |
